NeuroVive Pharmaceutical AB Deuda/Patrimonio neto
¿Qué es el Deuda/Patrimonio neto de NeuroVive Pharmaceutical AB?
El Deuda/Patrimonio neto de NeuroVive Pharmaceutical AB es 0.42
¿Cuál es la definición de Deuda/Patrimonio neto?
La relación deuda / patrimonio neto es una relación financiera que indica la proporción relativa del capital contable y la deuda utilizada para financiar los activos de una empresa.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Deuda/Patrimonio neto de compañías en Sector Health Care en OTC en comparadas con NeuroVive Pharmaceutical AB
¿Qué hace NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Empresas con deuda/patrimonio neto similar a NeuroVive Pharmaceutical AB
- Core Lithium Ltd tiene Deuda/Patrimonio neto de 0.42
- China Health tiene Deuda/Patrimonio neto de 0.42
- Vanguard Specialized Funds - Vanguard Real Estate ETF tiene Deuda/Patrimonio neto de 0.42
- Jagran Prakashan tiene Deuda/Patrimonio neto de 0.42
- Smc Electric tiene Deuda/Patrimonio neto de 0.42
- Indraprastha Medical tiene Deuda/Patrimonio neto de 0.42
- NeuroVive Pharmaceutical AB tiene Deuda/Patrimonio neto de 0.42
- PetroTal tiene Deuda/Patrimonio neto de 0.42
- West Pharmaceutical Services tiene Deuda/Patrimonio neto de 0.42
- Cybele Industries Ltd tiene Deuda/Patrimonio neto de 0.42
- Tandy Leather Factory tiene Deuda/Patrimonio neto de 0.42
- Nephros Inc tiene Deuda/Patrimonio neto de 0.42
- SiteMinder tiene Deuda/Patrimonio neto de 0.42